Elliot Maza President at Intellect Neurosciences, Inc. | Business Officer and Co-Founder at Various Life Science Companies
While working at IMMUNE PHARMACEUTICALS, Elliot Maza served as Board member, interim CEO and then President, CEO and Principal Financial Officer of clinical-stage.
Elliot Maza has exceptional expertise that include Technology Licensing Agreements, IPOs (traditional/ “reverse merger�), Finance and Accounting, Sourcing Capital, Business Model Development, Mergers & Acquisitions, Corporate Development, Process Improvement, Corporate Communications, Regulatory Compliance, and FDA submissions.
Elliot Maza is a talented professional known for his advanced understanding of life science entrepreneurship. He worked in a Biopharmaceutical Company to develop therapeutic agents for the treatment of immunologic and inflammatory diseases.
Elliot maza is the name and power behind a number of biotechnology companies that are solely concentrated on developing therapies for treatment and avoidance of neurodegenerative conditions.
Elliot maza is known for getting done with license agreements with Wyeth, Pfizer, Glaxo and ViroPharma (Shire) and multiple financings.
THANKS FOR YOUR ATTENTION Find out more about him at his official site http://elliotmaza.com/